FDA Drug Application (050219) for KAFOCIN by LILLY

Back to FDA Applications sponsored by LILLY

Application Number050219
Product Number001
FormCAPSULE;ORAL
Dosage250MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameKAFOCIN
Active IngredientCEPHALOGLYCIN



Back to FDA Applications sponsored by LILLY